Matthias Grothe, David Ellenberger, Felix von Podewils, Alexander Stahmann, Paulus S Rommer, Uwe K Zettl
{"title":"癫痫作为多发性硬化症疾病进展的预测因子。","authors":"Matthias Grothe, David Ellenberger, Felix von Podewils, Alexander Stahmann, Paulus S Rommer, Uwe K Zettl","doi":"10.1177/13524585211046739","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Epilepsy development during the course of multiple sclerosis (MS) is considered to be the result of cortical pathology. However, no long-term data exist on whether epilepsy in MS also leads to increasing disability over time.</p><p><strong>Objective: </strong>To examine if epilepsy leads to more rapid disease progression.</p><p><strong>Methods: </strong>We analyzed the data of 31,052 patients on the German Multiple Sclerosis Register in a case-control study.</p><p><strong>Results: </strong>Secondary progressive disease course (odds ratio (OR) = 2.23), age (OR = 1.12 per 10 years), and disability (OR = 1.29 per Expanded Disability Status Scale (EDSS) point) were associated with the 5-year prevalence of epilepsy. Patients who developed epilepsy during the course of the disease had a higher EDSS score at disease onset compared to matched control patients (EDSS 2.0 vs 1.5), progressed faster in each dimension, and consequently showed higher disability (EDSS 4.4 vs 3.4) and lower employment status (40% vs 65%) at final follow-up. After 15 years of MS, 64% of patients without compared to 54% of patients with epilepsy were not severely limited in walking distance.</p><p><strong>Conclusion: </strong>This work highlights the association of epilepsy on disability progression in MS, and the need for additional data to further clarify the underlying mechanisms.</p>","PeriodicalId":520714,"journal":{"name":"Multiple sclerosis (Houndmills, Basingstoke, England)","volume":" ","pages":"942-949"},"PeriodicalIF":5.0000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"9","resultStr":"{\"title\":\"Epilepsy as a predictor of disease progression in multiple sclerosis.\",\"authors\":\"Matthias Grothe, David Ellenberger, Felix von Podewils, Alexander Stahmann, Paulus S Rommer, Uwe K Zettl\",\"doi\":\"10.1177/13524585211046739\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Epilepsy development during the course of multiple sclerosis (MS) is considered to be the result of cortical pathology. However, no long-term data exist on whether epilepsy in MS also leads to increasing disability over time.</p><p><strong>Objective: </strong>To examine if epilepsy leads to more rapid disease progression.</p><p><strong>Methods: </strong>We analyzed the data of 31,052 patients on the German Multiple Sclerosis Register in a case-control study.</p><p><strong>Results: </strong>Secondary progressive disease course (odds ratio (OR) = 2.23), age (OR = 1.12 per 10 years), and disability (OR = 1.29 per Expanded Disability Status Scale (EDSS) point) were associated with the 5-year prevalence of epilepsy. Patients who developed epilepsy during the course of the disease had a higher EDSS score at disease onset compared to matched control patients (EDSS 2.0 vs 1.5), progressed faster in each dimension, and consequently showed higher disability (EDSS 4.4 vs 3.4) and lower employment status (40% vs 65%) at final follow-up. After 15 years of MS, 64% of patients without compared to 54% of patients with epilepsy were not severely limited in walking distance.</p><p><strong>Conclusion: </strong>This work highlights the association of epilepsy on disability progression in MS, and the need for additional data to further clarify the underlying mechanisms.</p>\",\"PeriodicalId\":520714,\"journal\":{\"name\":\"Multiple sclerosis (Houndmills, Basingstoke, England)\",\"volume\":\" \",\"pages\":\"942-949\"},\"PeriodicalIF\":5.0000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"9\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Multiple sclerosis (Houndmills, Basingstoke, England)\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/13524585211046739\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2021/10/1 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple sclerosis (Houndmills, Basingstoke, England)","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/13524585211046739","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/10/1 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 9
摘要
背景:多发性硬化症(MS)过程中癫痫的发展被认为是皮质病理的结果。然而,没有长期数据表明多发性硬化症的癫痫是否也会随着时间的推移而导致残疾的增加。目的:探讨癫痫是否会导致更快速的疾病进展。方法:我们在一项病例对照研究中分析了德国多发性硬化症登记册上31,052例患者的数据。结果:继发性进展病程(优势比(OR) = 2.23)、年龄(OR = 1.12 / 10年)和残疾(OR = 1.29 /扩展残疾状态量表(EDSS)点)与5年癫痫患病率相关。在疾病过程中发生癫痫的患者在发病时的EDSS评分高于匹配的对照患者(EDSS 2.0 vs 1.5),在每个维度上的进展更快,因此在最终随访时表现出更高的残疾(EDSS 4.4 vs 3.4)和更低的就业状况(40% vs 65%)。15年后,64%的非MS患者与54%的癫痫患者相比,步行距离没有严重限制。结论:这项工作强调了癫痫与MS残疾进展的关联,需要更多的数据来进一步阐明其潜在机制。
Epilepsy as a predictor of disease progression in multiple sclerosis.
Background: Epilepsy development during the course of multiple sclerosis (MS) is considered to be the result of cortical pathology. However, no long-term data exist on whether epilepsy in MS also leads to increasing disability over time.
Objective: To examine if epilepsy leads to more rapid disease progression.
Methods: We analyzed the data of 31,052 patients on the German Multiple Sclerosis Register in a case-control study.
Results: Secondary progressive disease course (odds ratio (OR) = 2.23), age (OR = 1.12 per 10 years), and disability (OR = 1.29 per Expanded Disability Status Scale (EDSS) point) were associated with the 5-year prevalence of epilepsy. Patients who developed epilepsy during the course of the disease had a higher EDSS score at disease onset compared to matched control patients (EDSS 2.0 vs 1.5), progressed faster in each dimension, and consequently showed higher disability (EDSS 4.4 vs 3.4) and lower employment status (40% vs 65%) at final follow-up. After 15 years of MS, 64% of patients without compared to 54% of patients with epilepsy were not severely limited in walking distance.
Conclusion: This work highlights the association of epilepsy on disability progression in MS, and the need for additional data to further clarify the underlying mechanisms.